Le Lézard
Classified in: Business
Subject: STR

IIROC Trading Resumption - ICO


VANCOUVER, Nov. 22, 2017 /CNW/ - Trading resumes in:

Company: iCo Therapeutics Inc.

TSX-Venture Symbol: ICO

Resumption (ET): 14:00

IIROC can make a decision to impose a temporary suspension (halt) of trading in a security of a publicly-listed company. Trading halts are implemented to ensure a fair and orderly market. IIROC is the national self-regulatory organization which oversees all investment dealers and trading activity on debt and equity marketplaces in Canada.

SOURCE Investment Industry Regulatory Organization of Canada (IIROC) - Halts/Resumptions


These press releases may also interest you

at 16:48
Endo, Inc. ("Endo" or the "Company"), a newly formed entity, today announced that it has successfully completed the previously announced acquisition of substantially all of the assets of Endo International plc ("EIP"), as contemplated under EIP's...

at 16:45
Ranger Energy Services, Inc. (the "Company") will report first quarter financial and operating results before the market opens for trading on Tuesday, May 7, 2024. Following the announcement, the Company's management will host an earnings conference...

at 16:43
This Is It! Southern Kitchen & Bar-B-Q is pleased to announce it will soon open its 10th location and 4th drive through location at 305 N. Morgan Street in LaGrange, GA . The opening of this new franchise establishment continues This Is It!'s 40-year...

at 16:42
The federal government recently delivered Budget 2024: Fairness for Every Generation. It is a plan to build a Canada that works better for everyone, where younger generations can get ahead, where their hard work pays off, and where they can buy a...

at 16:40
Seadrill Limited ("Seadrill" or the "Company") will report its first quarter 2024 results on Tuesday, May 14 after the NYSE closes for trading. The Company will host a conference call to discuss its results on Wednesday, May 15 at 09:00 CT / 16:00...

at 16:40
Trustmark Corporation reported net income of $41.5 million in the first quarter of 2024, representing diluted earnings per share of $0.68. Trustmark's performance during the first quarter produced a return on average tangible equity of 12.98% and a...



News published on and distributed by: